Exploring a Treatment Option for Patients with Previously Treated Metastatic Small Cell Lung Cancer (SCLC)

Jazz Pharmaceuticals
September 3, 2021

Jazz Pharmaceuticals is proud to sponsor a theater presentation during the 2021 Oncology Nursing Society (ONS) Bridge. We invite you to join this expert-led discussion Exploring a Treatment Option for Patients with Previously Treated Metastatic Small Cell Lung Cancer (SCLC).

• This program will explore:
  • An overview of unmet needs in SCLC
  • Current treatment guidelines for SCLC
  • Efficacy and safety findings from a study of an FDA-approved treatment for previously treated metastatic SCLC
  • Considerations for dosing, administration, and patient counseling

Click here to register for the live presentation on Tuesday, September 14th from 3:00 pm to 3:45 pm EST